Coverage Across 417 Genes
The Aventa Lymphoma test detects gene fusions and rearrangements in lymphomas from FFPE tumor tissue, revealing actionable insights missed by conventional FISH and sequencing techniques. The test is not susceptible to any of the technical limitations of conventional FISH and sequencing, resulting in better patient management.
The test is partner-agnostic and identifies the partner gene, whether or not it is on the gene list (e.g., MYC-IRAG2, SQSTM1-ALK where IRAG2 and SQSTM1 will be detected as the partners for these gene fusions, MYC and ALK, are on the panel).


Aventa Assist
Aventa is committed to ensuring access for all eligible patients. If insurance approves test coverage, patients are only responsible for their copay, coinsurance, and deductible. Their out-of-pocket cost may be further reduced if they are eligible for financial assistance through the Aventa Assist program. Please contact us if you have any questions.
Contact Us
Let us know if you have any questions about Aventa FusionPlus.